Glenmark Pharmaceuticals Financials
NSE: GLENMARK | BSE: 532296
₹2,438.30
₹38.30
(1.60%)
As on 26-Aug-2026IST
Market cap
₹68,863 Cr
Revenue (TTM)
₹17,737 Cr
P/E Ratio
38.3
P/B Ratio
6.3
Div. Yield
0.1 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
17,736.55
|
16,982.51
|
13,321.74
|
11,813.10
|
11,583.24
|
12,304.90
|
|
|
|
|
|
|
Total Income
|
18,236.50
|
17,443.13
|
13,435.46
|
12,653.09
|
11,872.14
|
12,471.58
|
|
|
|
|
|
|
Total Expenditure
|
12,939.86
|
12,410.09
|
10,970.36
|
10,617.77
|
9,948.23
|
9,984.60
|
|
|
|
|
|
|
EBITDA
|
4,796.69
|
4,572.42
|
2,351.38
|
1,195.33
|
1,635.01
|
2,320.30
|
|
|
|
|
|
|
Depreciation
|
616.73
|
573.48
|
486.01
|
581.91
|
569.17
|
486.72
|
|
|
|
|
|
|
EBIT
|
4,179.96
|
3,998.94
|
1,865.37
|
613.43
|
1,065.83
|
1,833.58
|
|
|
|
|
|
|
Interest
|
204.50
|
208.73
|
207.07
|
515.97
|
349.04
|
298.10
|
|
|
|
|
|
|
Other Income
|
499.94
|
460.62
|
113.72
|
839.99
|
288.90
|
166.67
|
|
|
|
|
|
|
Exceptional Items
|
-1,942.85
|
-2,266.08
|
-372.82
|
-900.96
|
-765.85
|
-260.91
|
|
|
|
|
|
|
Profit before Tax
|
2,532.56
|
1,984.75
|
1,399.21
|
36.50
|
239.84
|
1,441.25
|
|
|
|
|
|
|
Provision for Tax
|
734.75
|
622.79
|
352.07
|
1,867.35
|
329.40
|
447.60
|
|
|
|
|
|
|
Profit after Tax
|
1,797.81
|
1,361.95
|
1,047.14
|
-1,830.85
|
-89.56
|
993.65
|
|
|
|
|
|
|
Minority Interest
|
0.10
|
-0.10
|
-0.05
|
-68.15
|
-80.16
|
-51.94
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
1,797.90
|
1,361.85
|
1,047.10
|
-1,501.67
|
297.25
|
941.71
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
10,512.11
|
10,512.11
|
8,849.44
|
7,847.93
|
9,473.92
|
9,086.65
|
|
|
|
|
|
|
Minority Interest
|
0.10
|
-0.32
|
-0.37
|
-0.38
|
365.34
|
351.47
|
|
|
|
|
|
|
Non-Current Liabilities
|
3,019.66
|
1,773.05
|
109.35
|
-357.23
|
2,621.45
|
1,269.61
|
|
|
|
|
|
|
Current Liabilities
|
6,376.43
|
6,376.43
|
5,967.02
|
5,818.59
|
4,546.24
|
4,689.43
|
|
|
|
|
|
|
Total Liabilities
|
19,907.88
|
19,906.65
|
15,990.97
|
14,358.34
|
19,371.16
|
17,051.79
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
7,567.18
|
7,361.56
|
5,629.98
|
5,880.82
|
6,840.24
|
7,114.82
|
|
|
|
|
|
|
Current Assets
|
11,299.71
|
11,299.71
|
9,295.47
|
7,428.08
|
8,423.64
|
8,282.35
|
|
|
|
|
|
|
Total Assets
|
19,907.88
|
19,906.65
|
15,990.97
|
14,358.34
|
19,371.16
|
17,051.79
|
|
|
|
|
|
|
Total Debt*
|
--
|
--
|
2,194.20
|
990.60
|
4,347.72
|
3,670.35
|
|
|
|
|
|
|
Net Current Assets
|
4,923.28
|
4,923.28
|
3,328.44
|
1,609.50
|
3,877.40
|
3,592.92
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
787.81
|
800.26
|
1,063.30
|
336.69
|
361.31
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
3,445.03
|
-827.60
|
-265.44
|
625.39
|
1,108.65
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-1,283.23
|
2.09
|
4,560.89
|
-528.49
|
-333.28
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-2,708.75
|
787.05
|
-3,906.13
|
-77.46
|
-520.49
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-546.95
|
-38.46
|
389.32
|
19.45
|
254.88
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
109.89
|
48.26
|
37.11
|
-53.21
|
10.53
|
33.37
|
|
|
|
|
|
|
Cash EPS (₹)
|
63.70
|
68.58
|
54.33
|
-44.26
|
17.00
|
52.46
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
388.43
|
371.30
|
313.28
|
277.46
|
335.13
|
321.45
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.10
|
2.50
|
2.50
|
2.50
|
2.50
|
2.50
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
122.08
|
-29.33
|
-9.41
|
22.16
|
39.29
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
4.63
|
-60.64
|
-102.60
|
-41.13
|
4.57
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
20.35
|
16.16
|
4.88
|
4.43
|
14.19
|
|
|
|
|
|
|
ROE (%)
|
30.87
|
14.10
|
12.56
|
-21.18
|
-0.97
|
12.33
|
|
|
|
|
|
|
ROA (%)
|
10.00
|
8.11
|
7.42
|
-11.86
|
-0.54
|
6.74
|
|
|
|
|
|
|
EBIT Margin (%)
|
23.57
|
23.55
|
14.00
|
5.19
|
9.20
|
14.90
|
|
|
|
|
|
|
Net Margin (%)
|
9.86
|
7.81
|
7.79
|
-14.47
|
-0.75
|
7.97
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
5.59
|
5.34
|
-4.51
|
1.70
|
5.32
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
32.94
|
27.48
|
12.77
|
1.98
|
-5.86
|
12.44
|
|
|
|
|
|
|
EBIT Growth (%)
|
126.49
|
114.38
|
204.09
|
-42.45
|
-41.87
|
11.75
|
|
|
|
|
|
|
Net Profit Growth (%)
|
174.54
|
30.06
|
157.19
|
-1,944.25
|
-109.01
|
2.43
|
|
|
|
|
|
|
EPS Growth (%)
|
138.54
|
30.06
|
169.73
|
-605.16
|
-68.44
|
-2.92
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
18.53
|
12.91
|
-17.20
|
4.26
|
28.79
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
38.30
|
44.21
|
41.50
|
--
|
44.14
|
13.25
|
|
|
|
|
|
|
Price / Book Value
|
6.28
|
5.75
|
4.92
|
3.45
|
1.39
|
1.38
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.10
|
0.12
|
0.16
|
0.26
|
0.54
|
0.57
|
|
|
|
|
|
|
EV/EBITDA
|
12.78
|
11.73
|
17.83
|
12.95
|
8.48
|
5.93
|
|
|
|
|
|
|
Close Price (₹)
|
2,204.30
|
2,131.70
|
1,541.05
|
958.45
|
464.70
|
442.00
|
|
|
|
|
|
|
High Price (₹)
|
2,474.00
|
2,297.90
|
1,830.95
|
974.05
|
487.55
|
690.95
|
|
|
|
|
|
|
Low Price (₹)
|
1,740.10
|
1,336.00
|
958.00
|
444.30
|
348.50
|
415.60
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
68,862.82
|
60,201.30
|
43,458.18
|
27,020.10
|
13,120.33
|
12,477.17
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
0.25
|
0.13
|
0.46
|
0.40
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
0.19
|
0.11
|
0.04
|
0.04
|
|
|
|
|
|
|
Current Ratio
|
1.77
|
1.77
|
1.56
|
1.28
|
1.85
|
1.77
|
|
|
|
|
|
|
Quick Ratio
|
1.23
|
1.23
|
1.05
|
0.84
|
1.33
|
1.23
|
|
|
|
|
|
|
Interest Coverage
|
13.38
|
10.51
|
7.76
|
1.07
|
1.69
|
5.83
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
27.98
|
29.23
|
25.09
|
15.73
|
31.64
|
25.20
|
|
|
|
|
|
|
Asset Turnover
|
0.99
|
2.06
|
2.03
|
1.79
|
1.71
|
1.89
|
|
|
|
|
|
|
Receivable days
|
--
|
43.78
|
33.06
|
36.38
|
43.76
|
37.24
|
|
|
|
|
|
|
Inventory Days
|
--
|
34.05
|
35.23
|
32.19
|
31.52
|
31.35
|
|
|
|
|
|
|
Payable days
|
--
|
264.58
|
237.83
|
190.23
|
186.18
|
191.57
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-186.74
|
-169.54
|
-121.67
|
-110.90
|
-122.98
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
